Insights Lab
Latest insights, research and strategies to help support innovators to achieve real outcomes.
Latest Insights
For foreign life sciences companies considering Australia as an R&D location, the pull of the RDTI’s 43.5% headline rate for R&D expenditure can be significant. But the devil is often in the detail. Things like the aggregated turnover test, and whether the R&D is conducted on behalf of an Australian or foreign entity, can be determinative of whether an Australian subsidiary is eligible for the full refundable rate, a materially smaller refund, or a non-refundable tax offset it may never actually benefit from.
The last twelve months have been an interesting period for Queensland-based innovation funding. New programs focussed on developing sovereign capability and advanced manufacturing generated significant interest and represents opportunity for Queensland businesses with the right profile.
The proposed 2028 R&D Tax Incentive reforms are the Government's first substantive response to the Ambitious Australia Report, but how closely do they actually align? We've reviewed each of the seven proposed reforms against the Strategic Examination's recommendations, and mapped where the Government followed the evidence, where it softened it, and where it went its own way.
Our R&D Tax Facts is a summary of important developments in the world of the R&D Tax Incentive (RDTI) over the last 3 months.
The Queensland and Australian Governments have launched their jointly funded $50 million Local Digital Priority Projects (LDPP) program, providing significant funding for projects that strengthen digital infrastructure, accelerate AI and digital capability, and grow South-East Queensland's technology ecosystem.
New AI guidance has arrived for the R&D Tax Incentive providing insights on how the Department of Industry, Science & Resources view AI-related R&D activities and assess alignment with R&D tax requirements. Our latest article explores the key takeaways from the new guidance and why AI continues to be one of the most complex and evolving areas of the program.
The recent 2026-27 Federal Budget was one of the most significant in recent memory, announcing reforms and changes to established economic programs and schemes in the name of long-term economic resilience. Today’s edition focusses on the impact of the budget on innovation funding via competitive grant programs.
Where will your business land under the proposed 2028 R&D Tax Incentive reforms? Revenue, company age, and tax position each play a role. We've mapped key business profiles against the six proposed changes so you can identify your position before the rules take effect.
The NSW Government has opened Round 2 of its Net Zero Manufacturing Initiative, committing up to $225 million across three funding streams to accelerate industrial decarbonisation, strengthen sovereign manufacturing capability and support the commercialisation of next-generation clean technologies.
Stacking grants with the R&D Tax Incentive can create real upside if structured correctly. It can also quietly erode your benefit if the interaction rules aren't understood. We’ve broken down how it can work in practice.
As the end of the 2026 financial year approaches, businesses planning to access the R&D Tax Incentive should be reviewing a range of strategic, technical and administrative considerations prior to 30 June.
The 2026–27 Federal Budget has landed. And while the headlines are dominated by major policy changes to negative gearing, CGT, discretionary trusts and other tax relief measures, there are some genuinely important developments for Australia’s R&D and innovation ecosystem.
New AI guidance has arrived for the R&D Tax Incentive providing insights on how the Department of Industry, Science & Resources view AI-related R&D activities and assess alignment with R&D tax requirements. Our latest article explores the key takeaways from the new guidance and why AI continues to be one of the most complex and evolving areas of the program.
Where will your business land under the proposed 2028 R&D Tax Incentive reforms? Revenue, company age, and tax position each play a role. We've mapped key business profiles against the six proposed changes so you can identify your position before the rules take effect.
The Australian Government Department of Industry, Science and Resources (DISR) has released a series of six Issues Papers written by the independent Strategic Examination of Research and Development (SERD) panel and follow analysis of a published discussion paper and public submissions feedback on how to maximise the value of existing investment in R&D, strengthen linkages between research and industry, support the achievement of national priorities, drive greater R&D investment by industry and boost innovation, and uplifting Australia’s overall R&D intensity.
The R&D Tax Incentive (RDTI) program is a popular, broad-based funding program that covers a diverse range of industries and experimental work. It allows companies to offset certain costs incurred on eligible research and development activities each year. However, not all expenditure can be claimed, and there are a range of expenses that are excluded from being eligible R&D expenditure under the program.
Non‑dilutive funding can accelerate your innovation without giving up equity but navigating the grant landscape is tricky. A clear grant strategy helps you identify the right programs, prepare competitive applications, and avoid chasing grants that don’t fit.
An important reminder for Australian businesses with a 30 June year financial year that the deadline for lodging your 2023-24 R&D Tax Incentive (RDTI) Application is fast-approaching.
Featured Posts
Featured Grants
A federal government initiative with $150 million of matched funding available for this first round.
Case Studies
Over $1.5mill in funding secured across several State & Federal government grant funding programs will help the WiseRepro Group deliver its critical bovine reproduction services to more primary producers in regional Queensland and grow Australia’s bovine genetics export market.
LSQ engaged Intellect Labs to support a comprehensive strategic review to clarify its long-term direction, value proposition, and operating model.
Internet 2.0’s case illustrates how a well-prepared Overseas Funding application can lead to significant financial support and increased investor confidence. It underscores the importance of strategic planning and thorough documentation in the R&D tax incentive process.
With the help of the R&D Tax Incentive (‘RDTI’) program, Dataweavers is investing in R&D to deliver innovative solutions for deploying complex enterprise marketing technology and Digital Experience Platforms (DXPs) in the public cloud.
Ridley Corporation is accessing the R&D Tax Incentive (‘RDTI’) to help them drive innovation in Australian agriculture by providing advanced, sustainable animal nutrition solutions that assist farmers to enhance animal health and productivity while reducing environmental impact.
A $5m grant from the Medical Research Future Fund (MRFF) will help Southern RNA combine its new manufacturing capability with the Queensland research community to create an end-to-end mRNA translation ecosystem.
Start-up medical device company Neurode is accessing the Federal Government’s flagship innovation program, the R&D Tax Incentive (‘RDTI’), to improve quality of life for people diagnosed with ADHD.
Great Wrap is on a mission to remove the 150,000 tonnes of plastic stretch wrap sent to Australia’s landfill each year. A $535,000 grant from the Advanced Manufacturing Growth Centre will help them to do just that.
$2.57m from the Federal Government’s flagship manufacturing program will help Cyclowest fast-track production of next generation cancer treatments.